IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $330,000 | -17.3% | 16,255 | -34.5% | 0.02% | -17.9% |
Q2 2017 | $399,000 | -76.1% | 24,800 | -81.2% | 0.03% | -75.4% |
Q1 2017 | $1,666,000 | +495.0% | 131,700 | +524.2% | 0.11% | +500.0% |
Q4 2016 | $280,000 | -44.0% | 21,100 | 0.0% | 0.02% | -42.4% |
Q3 2016 | $500,000 | – | 21,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |